Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06342219
Other study ID # 423629
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 2024
Est. completion date June 2026

Study information

Verified date March 2024
Source University of Saskatchewan
Contact Faly Golshan, PhD Candidate
Phone 3062702765
Email faly.golshan@usask.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 135
Est. completion date June 2026
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - have a diagnosis of chronic migraine from a clinician or have met the criteria for a chronic migraine diagnosis based on ICHD-3 - reside in Saskatoon area - have a smartphone and internet connection for accessing the MUSE app - have no frequent background experience of meditation Exclusion Criteria: - Comorbidity of Raynaud's syndrome or diabetes - Current use of a preventative migraine treatment over 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Neurofeedback Mindfulness
The participants will use a portable EEG headband (MUSE) which is a noninvasive tool for collecting EEG data. They will receive real-time EEG data given an audio feedback while doing their daily mindfulness practice.
Attention Task
The participants in this arm will use the portable EEG while listening to an audiobook. They will receive a summary of their brain activities after task completion on each day.

Locations

Country Name City State
Canada University of Saskatchewan Saskatoon Saskatchewan

Sponsors (2)

Lead Sponsor Collaborator
University of Saskatchewan Saskatchewan Health Research Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Migraine Disability measured by Migraine Disability Assessment Scale (MIDAS) 8 weeks
Primary Migraine Severity measured by Headache Impact Test-short form (HIT-6) 8 weeks
Primary Headache management self-efficacy measured by Headache Management Self-Efficacy Scale 8 weeks
Primary Dependence on medicine measured by Severity of Dependence Scale (SDS) 8 weeks
Secondary Anxiety measured by BECK Anxiety Inventory (BAI) 8 weeks
Secondary Depression measured by The Center for Epidemiologic Studies Depression (CES-D) 8 weeks
See also
  Status Clinical Trial Phase
Terminated NCT04520425 - Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches N/A
Recruiting NCT06247592 - Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients N/A
Recruiting NCT06133491 - Open Label, 6-month Study for High Frequency and Chronic Migraine,
Recruiting NCT04989413 - Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine - Phase 4
Recruiting NCT06138171 - Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Active, not recruiting NCT06109389 - The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache Phase 2
Completed NCT04871581 - Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device N/A
Withdrawn NCT01749423 - A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines N/A
Terminated NCT04349176 - Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units? Phase 3
Completed NCT05381129 - The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine N/A
Withdrawn NCT03465826 - Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: AIM 4 N/A
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Completed NCT03767062 - Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches N/A
Completed NCT05748535 - Effect of Auricular Vagus Nerve Stimulation in Women With Migraine Disease N/A
Recruiting NCT05724771 - COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study Phase 4
Recruiting NCT05313503 - KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs N/A
Recruiting NCT05079659 - Rate , Predictors and Outcome of Chronic Migraine
Completed NCT03698409 - Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. Phase 4
Completed NCT06118190 - Mesotherapy in the Treatment of Chronic Migraine N/A
Completed NCT04017741 - A Study Investigating the Efficacy of GON Blocks. Phase 4